Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system

Journal of Immunology

Volumn 160, Issue 10, 1998, Pages 5181-5187

  Ludovic Croxford, J ^a   Triantaphyllopoulos, Kostas ^b   Podhajcer, Osvaldo L ^c   Feldmann, Marc ^b   Baker, David ^a   Chernajovsky, Yuti ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GENE THERAPY; IMMUNOMODULATION; MACROPHAGE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; BRAIN; CYTOKINES; DNA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE THERAPY; IMMUNOHISTOCHEMISTRY; INTERFERON-BETA; LIPOSOMES; MALE; MICE; PLASMIDS;

EID: 15444341849     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Mossman, T. R., and R. L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T-cells. Adv. Immunol. 46:111.
2. + T-cells. Annu. Rev. Immunol. 12:635.
3. Kennedy, M. K., D. S. Torrance, K. S. Picha, and K. M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental allergic encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
4. Issazadeh, S., A. Ljungdahl, B. Hojeberg, M. Mustafa, and T. Olsson. 1995. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for IL-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J. Neuroimmunol. 61:205.
5. Paty, D. W., and D. K. Li. 1993. Interferon beta is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter randomized double blind placebo-controlled trial. II. MRI analysis results. Neurology 43:655.
6. Baker, D., D. Butler, B. J. Scallon, J. K. O'Neill, J. L. Turk, and M. Feldmann. 1994. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24:2040.
7. Ruddle, N. H., C. M. Bergman, K. M. McGrath, E. G. Lingenheld, M. L. Grunnet, S. J. Padula, and R. B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193.
8. Selmaj, K., and C. S. Raine. 1988. Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol 23:339.
9. Neve, R., M. Kissonerghis, J. Clark, M. Feldmann, and Y. Chernajovsky. 1996. Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist. Cytokine 8:365.
10. Peppel, K., D. Crawford, and B. Beutler. 1991. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 174:1483.
11. Wood, M. J. A., H. M. Charlton, K. J. Wood, K. Kajiwara, and A. P. Byrnes. 1996. Immune responses to adenovirus vectors in the nervous system. Trends Neurosci. 19:497.
12. Jiao, S., P. Williams, R. K. Berg, B. A. Hodgeman, L. Liu, G. Repetto, and J. A. Wolff. 1992. Direct gene transfer into non-human primate myofibres in vivo. Hum. Gene Ther. 3:21.
13. Wolff, J. A., J. J. Ludtke, G. Ascadi, P. Williams, and A. Jani. 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:363.
14. Baker, D., J. K. O'Neill, S. E. Gschmeissner, C. E. Wilcox, C. Butter, and J. L. Turk. 1990. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol. 28:261.
15. O'Neill, J. K., D. Baker, A. N. Davison, K. K. Maggon, B. D. Jaffee, and J. L. Turk. 1992. Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier: elucidation by the action of Brequinar sodium. J. Neuroimmunol. 38:53.
16. Triantaphyllopoulos, K. A., J. L. Croxford, D. Baker, and Y. Chemajovsky. 1998. Cloning and expression of murine IFN-β and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis. Gene Ther. 5:253.
17. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587.
18. Chemajovsky, Y., G. Adams, K. Triantaphyllopoulos, M. F. Ledda, and O. L. Podhajcer. 1997. Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritis model. Gene Ther. 4:553.
19. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbeck, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R. C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine GMCSF stimulates potent, specific, and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90: 3539.
20. Chernajovsky, Y. 1998. Systemic gene therapy of arthritis. In: Innovative Therapies for Rheumatoid Arthritis. C. Evans and P. D. Robbins, eds. Prous Science, Barcelona, Spain, In press.
21. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and efficient amphotrophic packaging cell line. Virology 167:400.
22. Wells, D. J. 1995. Gene transfer via intramuscular injection of plasmid DNA. In: Molecular Cell Biology of Human Gene Therapeutics. Dickson G. ed. Chapman and Hall, London, pp 83-103.
23. Abrams, J. S., M. G. Roncarolo, H. Yssel, U. Anderson, G. J. Gleich, and J. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development. Immunol. Rev. 127:5.
24. Feigner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. 1987. Liporfection: a highly efficient lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413.
25. Ono, T., Y. Fujino, T. Tsuchiya, and M. Tsuda. 1990. Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells. Neurosci. Lett. 117:259.
26. Allen, S. J., D. Baker, J. K. O'Neill, A. N. Davison, and J. L. Turk. 1993. Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Cell. Immunol. 146:335.
27. Davis, H. L., R. G. Whalen, and B. A. Demeneix. 1993. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4:151.
28. Danko, I., J. D. Fritz, S. Jiao, K. Hogan, J. S. Latendresse, and J. A. Wolff. 1994. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther. 1:114.
29. Raz, E., A. Watanabe, S. M. Baird, R. A. Eisenberg, T. B. Parr, M. Lotz, T. J. Kipps, and D. A. Carson. 1993. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. USA 90:4523.
30. Manthorpe, M., F. Comefert-Jensen, J. Hartikka, J. Felgner, A. Rundell, M. Margalith, and V. Dwarski. 1993. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4:419.
31. Waisman, A., P. J. Ruiz, D. L. Hirschberg, A. Gelman, J. R. Oksenberg, S. Brocke, F. Mor, I. R. Cohen, and L. Steinman. 1996. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2:899.
32. Cao, L., Z. Zheng, Y. Zhao, Z. Jiang, Z. Liu, S. Chen, C. Zhou, and X. Liu. 1995. Gene therapy of Parkinson disease model rat by direct injection of plasmid DNA-lipofectin complex. Hum. Gene Ther. 6:1497.
33. Baker, D., J. K. O'Neill, A. N. Davison, and J. L. Turk. 1992. Control of immunemediated disease of the central nervous system requires the use of a neuroactive agent: elucidation by the action of mitoxantrone. clin. Exp. Immunol. 90:124.
34. Röcken, M. K., J. Urban, and E. M. Shevach. 1994. Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J. Exp. Med. 179:1885.
35. Ruuls, S. R., M. C. D. C. de Labie, K. S. Weber, C. A. D. Botman, R. J. Groenestein, C. D. Dijkstra, T. Olsson, and P. H. van der Meide. 1996. The length of treatment determines whether IFN-β prevents or aggravates experimental allergic autoimmune encephalomyelitis in Lewis rats. J. Immunol. 157:5721.
36. Racke, M. K., S. Dhib-Jalbut, B. Cannella, P. S. Albert, C. S. Raine, and D. E. McFarlin. 1991. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J. Immunol. 146: 3012.
37. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Röcken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
38. Baker, D., L. Steinman, and K. Gijbels. 1996. Cytokines in multiple sclerosis. In: Cytokines in Autoimmunity. F. M. Brennan and M. Feldmann, eds. Chapman and Hall, London, pp 77-99.
39. Chemajovsky, Y., G. Adams, O. L. Podhajcer, G. M. Mueller, P. D. Robbins, and M. Feldmann. 1995. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retro viruses expressing soluble tumor necrosis factor receptor. Gene Ther. 2:731.
40. Williams, R. O., J. Ghrayeb, M. Feldmann, and R. N. Maini. 1995. Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology 84:433.
41. Cross, A. H., T. O'Mara, and C. S. Raine. 1993. Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis. Neurology 43:1028.
42. Kömer, H., D. S. Riminton, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1997. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1585.
43. Santos, L. M., A. al-Sabbagh, A. Londono, and H. L. Weiner. 1994. Oral tolerance to myelin basic protein induces regulatory TGF-β-secreting T cells in Peyer's patches of SJL mice, Cell. Immunol. 157:439.
44. Wyss-Coray, T., P. Borrow, M. J. Brooker, and L. Mucke. 1997. Astroglial over-production of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice. J. Neuroimmunol. 77:45.
45. Jacobs, L., A. M. Salazar, R. Herndon, P. A. Reese, A. Freeman, R. Josefowicz, A. Guetter, F. Husain, W. A. Smith, R. Ekes, and J. A. O'Malley. 1986. Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon exacerbations of multiple sclerosis. Lancet ii:1411.
46. Yu, M., A. Nishiyama, B. D. Trapp, and V. K. Tuohy. 1996. Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J. Neuroimmunol. 64:91.
47. Panitch, H. S., R. L. Hirsch, J. Schindler, and K. P. Johnson. 1987. Treatment of multiple sclerosis with γ Interferon: exacerbations associated with activation of the immune system. Neurology 37:1097.
48. Rott, O., B. Fleischer, and E. Cash. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1434.
49. Mathisen, P. M., M. Yu, J. M. Johnson, J. A. Drazba, and V. K. Tuohy. 1997. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186:159.
50. Cannella, B., Y. L. Gao, C. Brosnan, and C. S. Raine. 1996. IL-10 fails to abrogate experimental allergic encephalomyelitis. J. Neurosci. Res. 45:735.
51. Shaw, M. K., J. B. Lorens, A. Dhawan, R. DalCanto, H. Y. Tse, A. B. Tran, C. Bonpane, S. L. Eswaran, S. Brocke, N. Sarvetnick, L. Steinman, G. P. Nolan, and C. G. Fathman. 1997. Local delivery of interleukin 4 by retro virus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1711.
52. Leinwand, L. A., and J. M. Leiden. 1991. Gene transfer into cardiac myocytes in vivo. Trends Cardiovascular. Med. 1:271.
53. Leiden, J. M., and E. Barr. 1994. In vivo gene transfer into the heart. In Gene Therapeutics: Methods and Applications of Direct Gene Transfer. J. A. Wolff, ed. Birkhauser, Boston, p. 363.
54. Gal, D., L. Weir, G. Leclerc, J. G. Pickering, J. Hogan, and J. M. Isner. 1993. Direct myocardial transfection in two animal models: evaluation of parameters affecting gene expression and percutaneous gene delivery. Lab. Invest. 68:18.